These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15691218)

  • 1. Modulating effects of intravenous immunoglobulins on serum cytokine levels in patients with primary hypogammaglobulinemia.
    Ibáñez C; Suñé P; Fierro A; Rodríguez S; López M; Alvarez A; De Gracia J; Montoro JB
    BioDrugs; 2005; 19(1):59-65. PubMed ID: 15691218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Release of cytokines, soluble cytokine receptors, and interleukin-1 receptor antagonist after intravenous immunoglobulin administration in vivo.
    Aukrust P; Frøland SS; Liabakk NB; Müller F; Nordøy I; Haug C; Espevik T
    Blood; 1994 Oct; 84(7):2136-43. PubMed ID: 7919327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin replacement therapy in the treatment of patients with common variable immunodeficiency disease: an open-label prospective study.
    Kasztalska K; Ciebiada M; Cebula-Obrzut B; Górski P
    Clin Drug Investig; 2011; 31(5):299-307. PubMed ID: 21473654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo modulation of cytokine synthesis by intravenous immunoglobulin.
    Sewell WA; North ME; Cambronero R; Webster AD; Farrant J
    Clin Exp Immunol; 1999 Jun; 116(3):509-15. PubMed ID: 10361243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytokines in children with immunodeficiencies].
    Kowalczyk D
    Folia Med Cracov; 1999; 40(1-2):5-97. PubMed ID: 10909468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pemphigus vulgaris: the role of IL-1 and IL-1 receptor antagonist in pathogenesis and effects of intravenous immunoglobulin on their production.
    Bhol KC; Desai A; Kumari S; Colon JE; Ahmed AR
    Clin Immunol; 2001 Aug; 100(2):172-80. PubMed ID: 11465946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment.
    Gupta M; Noel GJ; Schaefer M; Friedman D; Bussel J; Johann-Liang R
    J Clin Immunol; 2001 May; 21(3):193-9. PubMed ID: 11403226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immune globulin affects cytokine production in T lymphocytes and monocytes/macrophages.
    Andersson J; Skansén-Saphir U; Sparrelid E; Andersson U
    Clin Exp Immunol; 1996 May; 104 Suppl 1():10-20. PubMed ID: 8625537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum levels of interleukin-6 and interleukin-10 in patients with multiple sclerosis during intravenous immunoglobulin infusion].
    Kazibutowska Z; Motta E; Huć M; Strzała-Orzeł M; Woźnik G
    Wiad Lek; 2006; 59(9-10):626-9. PubMed ID: 17338118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg?
    Crow AR; Song S; Semple JW; Freedman J; Lazarus AH
    Blood; 2007 Jan; 109(1):155-8. PubMed ID: 16954498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluctuations in quality of life and immune responses during intravenous immunoglobulin infusion cycles.
    Abbott JK; Chan SK; MacBeth M; Crooks JL; Hancock C; Knight V; Gelfand EW
    PLoS One; 2022; 17(3):e0265852. PubMed ID: 35316278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin 1 components in cicatricial pemphigoid. Role in intravenous immunoglobulin therapy.
    Kumari S; Bhol KC; Rehman F; Foster CS; Ahmed AR
    Cytokine; 2001 May; 14(4):218-24. PubMed ID: 11448121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of intravenous immunoglobulin (IVIG) in vivo--down-regulatory effects on the IL-1 system.
    Aukrust P; Müller F; Svenson M; Nordøy I; Bendtzen K; Frøland SS
    Clin Exp Immunol; 1999 Jan; 115(1):136-43. PubMed ID: 9933433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intravenous immunoglobulins on T cell and oligodendrocyte apoptosis in high-dose antigen therapy in experimental autoimmune encephalomyelitis.
    Weishaupt A; Kuhlmann T; Schönrock LM; Toyka KV; Brück W; Gold R
    Acta Neuropathol; 2002 Oct; 104(4):385-90. PubMed ID: 12200625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alteration of cytokines in serum and cerebrospinal fluid before and after high-dose immunoglobulin therapy in patients with West syndrome].
    Matsuura R; Hamano SI; Hirata Y; Oba A; Kumagai Y; Suzuki K; Koichihara R; Kikuchi K; Tanaka M; Minamitani M
    No To Hattatsu; 2016 Jul; 48(4):247-51. PubMed ID: 30010305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphokine production induced by streptococcal pyrogenic exotoxin-A is selectively down-regulated by pooled human IgG.
    Skansén-Saphir U; Andersson J; Björk L; Andersson U
    Eur J Immunol; 1994 Apr; 24(4):916-22. PubMed ID: 8149962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of proliferation and tumor necrosis factor-alpha production occurring during mixed lymphocyte reaction by interferon-gamma-specific natural antibodies contained in intravenous immunoglobulins.
    Toungouz M; Denys C; Dupont E
    Transplantation; 1996 Nov; 62(9):1292-6. PubMed ID: 8932274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Natural History of Untreated Primary Hypogammaglobulinemia in Adults: Implications for the Diagnosis and Treatment of Common Variable Immunodeficiency Disorders (CVID).
    Ameratunga R; Ahn Y; Steele R; Woon ST
    Front Immunol; 2019; 10():1541. PubMed ID: 31379811
    [No Abstract]   [Full Text] [Related]  

  • 19. Selective induction of interleukin-1 receptor antagonist and interleukin-8 in human monocytes by normal polyspecific IgG (intravenous immunoglobulin).
    Ruiz de Souza V; Carreno MP; Kaveri SV; Ledur A; Sadeghi H; Cavaillon JM; Kazatchkine MD; Haeffner-Cavaillon N
    Eur J Immunol; 1995 May; 25(5):1267-73. PubMed ID: 7774630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prior poliomyelitis-IVIg treatment reduces proinflammatory cytokine production.
    Gonzalez H; Khademi M; Andersson M; Piehl F; Wallström E; Borg K; Olsson T
    J Neuroimmunol; 2004 May; 150(1-2):139-44. PubMed ID: 15081258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.